跳至主要内容
临床试验/ISRCTN02859773
ISRCTN02859773已完成不适用

ycopene and vitamin E in men with minimal prostate cancer and rising prostate specific antigen after radical prostatectomy: a double blind randomised placebo controlled cross-over study

BASF Aktiengesellschaft (Germany)0 个研究点目标入组 80 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Status after radical prostatectomy with potential curative intent
  • 2. Rising PSA
  • 3. Life expectancy more than or equal to 12 months
  • 4. Age more than or equal to 18 years

排除标准

  • 1. Current hormone therapy or hormone therapy during previous 12 months
  • 2. Orchidectomy
  • 3. Chemotherapy, radiotherapy or transurethral resection of the prostate (TURP) prior to study resulting in PSA decrease that is currently ongoing

研究者

发起方
BASF Aktiengesellschaft (Germany)

相似试验